Dishit P. Ghumra

Dishit P. Ghumra

Auto-generated profile, based on publicly available information

Dishit P. Ghumra

Center for Aerosol Science and Engineering, Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, Missouri 63130, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JPJoseph V. Puthussery
Joseph V. Puthussery
DGDishit P. Ghumra
Dishit P. Ghumra
KMKevin R. McBrearty
Kevin R. McBrearty
BDBrookelyn M. Doherty
Brookelyn M. Doherty
BSBenjamin J. Sumlin
Benjamin J. Sumlin
RCRajan K. Chakrabarty
Rajan K. Chakrabarty
Real-time surveillance of airborne SARS-CoV-2 virus is a technological gap that has eluded the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling techniques for SARS-CoV-2 detection suffer from longer turnaround times and require skilled labor. Here, we present a proof-of-concept pathogen Air Quality (pAQ) monitor for real-time (5 min time resolution) direct detection of SARS-CoV-2 aerosols. The system synergistically integrates a high flow (~1000 lpm) wet cyclone air sampler and a nanobody-based ultrasensitive micro-immunoelectrode biosensor. The wet cyclone showed comparable or better virus sampling performance than commercially available samplers. Laboratory experiments demonstrate a device sensitivity of 77–83% and a limit of detection of 7-35 viral RNA copies/m3 of air. Our pAQ monitor is suited for point-of-need surveillance of SARS-CoV-2 variants in indoor environments and can be adapted for multiplexed detection of other respiratory pathogens of interest. Widespread adoption of such technology could assist public health officials with implementing rapid disease control measures.

1 March 2021 in Process Safety and Environmental Protection
Verified
Journal Article
Closed access
DGDishit P. Ghumra
Dishit P. Ghumra
CAChandrodai Agarkoti
Chandrodai Agarkoti
PGParag R. Gogate
Parag R. Gogate

27 July 2023 in ACS Sensors
Verified
Journal Article
Open access
DGDishit P. Ghumra
Dishit P. Ghumra
NSNishit Shetty
Nishit Shetty
KMKevin R. McBrearty
Kevin R. McBrearty
JPJoseph V. Puthussery
Joseph V. Puthussery
BSBenjamin J. Sumlin
Benjamin J. Sumlin
RCRajan K. Chakrabarty
Rajan K. Chakrabarty
Airborne transmission via virus-laden aerosols is a dominant route for the transmission of respiratory diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Direct, non-invasive screening of respiratory virus aerosols in patients has been a long-standing technical challenge. Here, we introduce a point-of-care testing platform that directly detects SARS-CoV-2 aerosols in as little as two exhaled breaths of patients and provides results in under 60 s. It integrates a hand-held breath aerosol collector and a llama-derived, SARS-CoV-2 spike-protein specific nanobody bound to an ultrasensitive micro-immunoelectrode biosensor, which detects the oxidation of tyrosine amino acids present in SARS-CoV-2 viral particles. Laboratory and clinical trial results were within 20% of those obtained using standard testing methods. Importantly, the electrochemical biosensor directly detects the virus itself, as opposed to a surrogate or signature of the virus, and is sensitive to as little as 10 viral particles in a sample. Our platform holds the potential to be adapted for multiplexed detection of different respiratory viruses. It provides a rapid and non-invasive alternative to conventional viral diagnostics.